330 related articles for article (PubMed ID: 19100256)
1. Identification of a novel 5-HT(4) receptor splice variant (r5-HT(4c1)) and preliminary characterisation of specific 5-HT(4a) and 5-HT(4b) receptor antibodies.
Ray AM; Kelsell RE; Houp JA; Kelly FM; Medhurst AD; Cox HM; Calver AR
Eur J Pharmacol; 2009 Feb; 604(1-3):1-11. PubMed ID: 19100256
[TBL] [Abstract][Full Text] [Related]
2. Alternative splicing and exon duplication generates 10 unique porcine 5-HT 4 receptor splice variants including a functional homofusion variant.
De Maeyer JH; Aerssens J; Verhasselt P; Lefebvre RA
Physiol Genomics; 2008 Jun; 34(1):22-33. PubMed ID: 18430808
[TBL] [Abstract][Full Text] [Related]
3. Expression and function of 5-HT4 receptors in the mouse enteric nervous system.
Liu M; Geddis MS; Wen Y; Setlik W; Gershon MD
Am J Physiol Gastrointest Liver Physiol; 2005 Dec; 289(6):G1148-63. PubMed ID: 16037544
[TBL] [Abstract][Full Text] [Related]
4. Cloning, expression and pharmacology of a truncated splice variant of the human 5-HT7 receptor (h5-HT7b).
Jasper JR; Kosaka A; To ZP; Chang DJ; Eglen RM
Br J Pharmacol; 1997 Sep; 122(1):126-32. PubMed ID: 9298538
[TBL] [Abstract][Full Text] [Related]
5. SL65.0155, a novel 5-hydroxytryptamine(4) receptor partial agonist with potent cognition-enhancing properties.
Moser PC; Bergis OE; Jegham S; Lochead A; Duconseille E; Terranova JP; Caille D; Berque-Bestel I; Lezoualc'h F; Fischmeister R; Dumuis A; Bockaert J; George P; Soubrié P; Scatton B
J Pharmacol Exp Ther; 2002 Aug; 302(2):731-41. PubMed ID: 12130738
[TBL] [Abstract][Full Text] [Related]
6. Pituitary adenylyl cyclase-activating polypeptide (PACAP) and its receptor (PAC1-R) in the cochlea: evidence for specific transcript expression of PAC1-R splice variants in rat microdissected cochlear subfractions.
Abu-Hamdan MD; Drescher MJ; Ramakrishnan NA; Khan KM; Toma VS; Hatfield JS; Drescher DG
Neuroscience; 2006 Jun; 140(1):147-61. PubMed ID: 16626868
[TBL] [Abstract][Full Text] [Related]
7. Identification, molecular cloning, and distribution of a short variant of the 5-hydroxytryptamine2C receptor produced by alternative splicing.
Canton H; Emeson RB; Barker EL; Backstrom JR; Lu JT; Chang MS; Sanders-Bush E
Mol Pharmacol; 1996 Oct; 50(4):799-807. PubMed ID: 8863824
[TBL] [Abstract][Full Text] [Related]
8. Decreased agonist, but not antagonist, binding to the naturally occurring Thr92Lys variant of the h5-HT7(a) receptor.
Brüss M; Kiel S; Bönisch H; Kostanian A; Göthert M
Neurochem Int; 2005 Aug; 47(3):196-203. PubMed ID: 15896881
[TBL] [Abstract][Full Text] [Related]
9. Cloning, genomic organization and functionality of 5-HT(7) receptor splice variants from mouse brain.
Gellynck E; Laenen K; Andressen KW; Lintermans B; De Martelaere K; Matthys A; Levy FO; Haegeman G; Vanhoenacker P; Van Craenenbroeck K
Gene; 2008 Dec; 426(1-2):23-31. PubMed ID: 18793707
[TBL] [Abstract][Full Text] [Related]
10. Cloning, pharmacological characterisation and tissue distribution of a novel 5-HT4 receptor splice variant, 5-HT4(i).
Brattelid T; Kvingedal AM; Krobert KA; Andressen KW; Bach T; Hystad ME; Kaumann AJ; Levy FO
Naunyn Schmiedebergs Arch Pharmacol; 2004 Jun; 369(6):616-28. PubMed ID: 15118808
[TBL] [Abstract][Full Text] [Related]
11. 5HT4(a) and 5-HT4(b) receptors have nearly identical pharmacology and are both expressed in human atrium and ventricle.
Bach T; Syversveen T; Kvingedal AM; Krobert KA; Brattelid T; Kaumann AJ; Levy FO
Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb; 363(2):146-60. PubMed ID: 11218067
[TBL] [Abstract][Full Text] [Related]
12. Activation of 5-HT3 receptors in the rat and mouse intestinal tract: a comparative study.
Chetty N; Irving HR; Coupar IM
Br J Pharmacol; 2006 Aug; 148(7):1012-21. PubMed ID: 16770318
[TBL] [Abstract][Full Text] [Related]
13. Discovery of naturally occurring splice variants of the rat histamine H3 receptor that act as dominant-negative isoforms.
Bakker RA; Lozada AF; van Marle A; Shenton FC; Drutel G; Karlstedt K; Hoffmann M; Lintunen M; Yamamoto Y; van Rijn RM; Chazot PL; Panula P; Leurs R
Mol Pharmacol; 2006 Apr; 69(4):1194-206. PubMed ID: 16415177
[TBL] [Abstract][Full Text] [Related]
14. Internalization of human 5-HT4a and 5-HT4b receptors is splice variant dependent.
Pindon A; Van Hecke G; Josson K; Van Gompel P; Lesage A; Leysen JE; Jurzak M
Biosci Rep; 2004 Jun; 24(3):215-23. PubMed ID: 16209130
[TBL] [Abstract][Full Text] [Related]
15. Novel brain-specific 5-HT4 receptor splice variants show marked constitutive activity: role of the C-terminal intracellular domain.
Claeysen S; Sebben M; Becamel C; Bockaert J; Dumuis A
Mol Pharmacol; 1999 May; 55(5):910-20. PubMed ID: 10220570
[TBL] [Abstract][Full Text] [Related]
16. The human 5-HT7 serotonin receptor splice variants: constitutive activity and inverse agonist effects.
Krobert KA; Levy FO
Br J Pharmacol; 2002 Mar; 135(6):1563-71. PubMed ID: 11906971
[TBL] [Abstract][Full Text] [Related]
17. Appearance of a ventricular 5-HT4 receptor-mediated inotropic response to serotonin in heart failure.
Qvigstad E; Brattelid T; Sjaastad I; Andressen KW; Krobert KA; Birkeland JA; Sejersted OM; Kaumann AJ; Skomedal T; Osnes JB; Levy FO
Cardiovasc Res; 2005 Mar; 65(4):869-78. PubMed ID: 15721867
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the pharmacological properties of guinea-pig and human recombinant 5-HT4 receptors.
Vickery RG; Mai N; Kaufman E; Beattie DT; Pulido-Rios T; O'Keefe M; Humphrey PP; Smith JA
Br J Pharmacol; 2007 Mar; 150(6):782-91. PubMed ID: 17293885
[TBL] [Abstract][Full Text] [Related]
19. Discrimination in 5-HT(3) receptor binding in murine brain and cultured cell preparations.
Zhang ZJ; Trivedi BL; de Paulis T; Schmidt DE; Hewlett WA
Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):123-32. PubMed ID: 11819030
[TBL] [Abstract][Full Text] [Related]
20. Molecular cloning and functional expression of the mouse CRF2(a) receptor splice variant.
Dautzenberg FM; Higelin J; Wille S; Brauns O
Regul Pept; 2004 Sep; 121(1-3):89-97. PubMed ID: 15256278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
